InvestorsHub Logo
Followers 1106
Posts 279775
Boards Moderated 10
Alias Born 03/18/2011

Re: None

Friday, 10/24/2014 5:31:59 AM

Friday, October 24, 2014 5:31:59 AM

Post# of 616852
Rosetta Genomics' microRNA-based assay for Thyroid Cancer Highlighted in Poster Presentation at 84th Annual Meeting of the American Thyroid Association
[Business Wire] - Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics, announces that data in support of the Company’s microRNA-based assay
10/23/2014 07:00 AM

http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/rosetta-genomics-microrna-based-assay-120000115.html

Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.